DENTSPLY SIRONA (XRAY) CEO reports tax-withholding share disposition on RSU vesting

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. President and CEO Daniel T. Scavilla reported a small share disposition tied to equity compensation. On the transaction date, 1,194.48 shares of common stock were withheld at a price of $13.14 per share to cover taxes on vested restricted stock units and related dividend equivalent units. After this tax-withholding disposition, Scavilla directly owned 16,750.066 shares of DENTSPLY SIRONA common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Scavilla Daniel T

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28277

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, CEO & Member of BOD

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/24/2026		F		1,194.48(1)	D	$13.14	16,750.066	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I.

	/s/ Jessica Nielsen Causey, Attorney-in-Fact for Daniel T. Scavilla	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DENTSPLY SIRONA (XRAY) report for Daniel T. Scavilla?

Daniel T. Scavilla reported a tax-related share disposition. The company withheld 1,194.48 common shares to cover taxes on vested restricted stock units and related dividend equivalent units, rather than an open-market sale of shares.

Was the XRAY CEO’s Form 4 transaction an open-market sale of shares?

No, the transaction was not an open-market sale. Shares were withheld by the company to satisfy tax obligations arising from the vesting of restricted stock units and dividend equivalent units previously granted to the CEO.

How many DENTSPLY SIRONA (XRAY) shares were withheld for taxes in this Form 4?

A total of 1,194.48 DENTSPLY SIRONA common shares were withheld. These shares covered the reporting person’s tax liability tied to the vesting of restricted stock units and associated dividend equivalent units, as described in the Form 4 footnote.

At what price were the withheld XRAY shares valued in the CEO’s Form 4?

The withheld shares were valued at $13.14 per share. This price was used to determine the value of the 1,194.48 common shares applied toward satisfying the CEO’s tax obligations from the vesting equity awards.

How many XRAY shares does Daniel T. Scavilla own after this reported transaction?

After this tax-withholding disposition, Daniel T. Scavilla directly owned 16,750.066 DENTSPLY SIRONA common shares. This figure reflects his remaining direct holdings following the shares withheld to cover taxes on vested restricted stock units.